Trial intelligence / Profile preview

Vitamin D therapy in elderly diabetic patients with COVID-19

NCT04733625Completed

Sponsor
Kasr Al Ainy Hospital
Start
Sep 2020
Primary completion
Dec 2020
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) and Vitamin D deficiency (VDD) comparing Vitamin D Arm with Placebo Arm (2 arms). Primary endpoint: Death or need for intubation at 6 weeks. Started Sep 2020; status: completed.

02

Drugs

vitamin d
03

Conditions

coronavirus disease 2019 (COVID-19)Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT04733625.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04733625.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call